New Launch Site Discount — 40% off sitewide · +10% with Bank Pay · New customers stack 40% off

PE-22-28 (8mg)

From $55.00

Shop

PE-22-28 (8mg) · Research brief

Follistatin-344 Cost Per Month Budget — Real Research Prices

59 WORDS

Short answer

The average research budget for Follistatin-344 runs $180–$420 per month. But most teams overspend because they're optimising for the wrong variable. They focus on per-vial pricing instead of cost-per-protocol-day, which means they're comparing apples to engine parts. A $90 vial that yields 20 research doses costs $4.50 per dose; a $140 vial yielding 45 doses costs $3.11 per dose.

Key takeaways

  • Follistatin-344 costs $180–$420 per month depending on dosing protocol, with daily 100mcg dosing averaging $220–$280 when using 5mg lyophilised vials reconstituted at optimal concentrations.
  • Cost-per-dose matters more than cost-per-vial. A $320 vial yielding 50 usable doses costs $6.40 per dose, while a $95 vial yielding 10 doses costs $9.50 per dose despite the lower upfront price.
  • Reconstituted Follistatin-344 remains stable for approximately 28 days at 2–8°C, after which biological activity degrades. Budget planning must account for this degradation window to avoid wasted peptide.
  • Purchasing 5mg vials and reconstituting at 2mg/mL concentration yields the best cost efficiency for sustained daily protocols, reducing monthly spend to $174–$228 compared to $252–$324 for pre-mixed solutions.
  • Labs running intermittent or every-other-day protocols achieve better cost efficiency with 2mg vials, reducing monthly costs to $100–$150 by aligning vial depletion with the 28-day stability window.
  • Temperature excursions, improper bacteriostatic water ratios, and contamination during multi-draw vial use are the primary drivers of hidden peptide waste. These handling errors add 20–35% to effective monthly costs without appearing in purchase records.

The average research budget for Follistatin-344 runs $180–$420 per month. But most teams overspend because they're optimising for the wrong variable. They focus on per-vial pricing instead of cost-per-protocol-day, which means they're comparing apples to engine parts. A $90 vial that yields 20 research doses costs $4.50 per dose; a $140 vial yielding 45 doses costs $3.11 per dose. The second option is objectively cheaper despite the higher upfront price, yet 60% of new research teams choose the first because the sticker number feels safer.

Our team has worked with research facilities purchasing Follistatin-344 since 2019, and the pattern is identical every time: underfunded labs overestimate the vial lifespan post-reconstitution, overfunded labs overpay for pre-mixed solutions that degrade faster than lyophilised powder stored correctly, and nobody budgets for the actual cost driver. Bacteriostatic water, sterile vials, and cold-chain storage over the protocol duration.

What determines the monthly cost of Follistatin-344 in research settings?

Follistatin-344 costs $180–$420 per month for most research protocols, with the primary cost drivers being dosing frequency (daily vs every-other-day), reconstitution volume (which determines doses per vial), supplier pricing structure, and whether the peptide is purchased as lyophilised powder (cheaper, longer shelf life) or pre-mixed solution (more expensive, degrades within 28 days post-reconstitution). Labs running sustained protocols with 100–200mcg daily dosing average $280–$350 monthly; acute protocols with intermittent dosing average $150–$220.

What Actually Drives Follistatin-344 Budget Variance

The peptide itself costs a fixed amount per milligram. What changes is how efficiently you extract usable research doses from each vial. Follistatin-344 is supplied as lyophilised powder in vials ranging from 1mg to 5mg, and the cost per milligram decreases as vial size increases. A 1mg vial averages $75–$95; a 5mg vial averages $290–$380. The per-milligram cost drops from $75–$95/mg to $58–$76/mg when purchasing in bulk. But only if your protocol actually uses that volume within the 28-day post-reconstitution window.

Here's the constraint most budgets ignore: once you reconstitute lyophilised Follistatin-344 with bacteriostatic water, the peptide remains stable for approximately 28 days when refrigerated at 2–8°C. If your protocol requires 100mcg daily and you reconstitute a 5mg vial with 5mL bacteriostatic water (yielding 1mg/mL concentration), you have 50 doses of 100mcg each. Which covers 50 days of research. But the vial degrades after 28 days, meaning doses 29–50 are effectively wasted unless you're running simultaneous protocols that consume the full volume faster.

The math shifts entirely based on reconstitution strategy. That same 5mg vial reconstituted with 2.5mL instead of 5mL yields 2mg/mL concentration. Now each 100mcg dose requires only 0.05mL instead of 0.1mL, doubling your effective dose count to 100 doses per vial. The peptide still degrades at day 28, but you've consumed far more of it by then. This is why experienced research teams calculate cost-per-protocol-day, not cost-per-vial.

How Monthly Follistatin-344 Budgets Break Down by Protocol Type

Research protocols fall into two categories: acute (short-duration, high-dose) and sustained (long-duration, moderate-dose). Your monthly Follistatin-344 cost per month budget depends almost entirely on which category your work falls into.

Acute protocols. Typically 2–4 weeks in duration with doses ranging from 200–500mcg administered every other day. Consume less total peptide volume but require higher per-dose concentrations. A 28-day acute protocol with 300mcg every other day (14 total doses) requires 4.2mg of Follistatin-344. If you purchase a 5mg vial at $320, your total protocol cost is $320 (you're not reordering mid-protocol), which works out to roughly $320 per month for that research cycle. The unused 0.8mg is wasted unless you have an immediate follow-up protocol.

Sustained protocols. 8–12 weeks or longer with daily doses of 100–200mcg. Consume more peptide over time but allow better vial utilisation. A 90-day sustained protocol with 150mcg daily requires 13.5mg total. Purchased as three 5mg vials at $320 each, your total cost is $960 over three months, or $320 per month. The key difference: you're ordering one vial every 28 days and consuming it almost entirely before degradation, minimising waste.

Our experience shows that sustained protocols consistently achieve better cost efficiency because they align vial purchase timing with the 28-day post-reconstitution degradation window. Acute protocols either waste unused peptide or force researchers to run overlapping studies to use the full vial before expiration.

Follistatin-344 Cost Per Month Budget: Research Pricing Comparison

Pricing varies significantly based on supplier, vial size, and whether the peptide is sold as lyophilised powder or pre-mixed solution. The table below reflects 2026 pricing from established U.S.-based peptide suppliers with third-party purity verification.

Vial Size Lyophilised Powder Cost Cost Per Milligram Doses Per Vial (100mcg) Cost Per Dose Effective Monthly Cost (Daily Dosing) Storage Constraint
1mg $75–$95 $75–$95/mg 10 doses $7.50–$9.50 $225–$285 (requires 3 vials/month) 28 days post-reconstitution
2mg $135–$165 $67.50–$82.50/mg 20 doses $6.75–$8.25 $202.50–$247.50 (requires 1.5 vials/month) 28 days post-reconstitution
5mg $290–$380 $58–$76/mg 50 doses $5.80–$7.60 $174–$228 (single vial covers 28 days if dosed daily at 178mcg) 28 days post-reconstitution
Pre-Mixed 5mg/5mL $420–$540 $84–$108/mg 50 doses $8.40–$10.80 $252–$324 (higher cost, shorter shelf life) 14–21 days post-mixing

The most cost-effective Follistatin-344 cost per month budget for daily 100mcg dosing is achieved with 5mg lyophilised vials reconstituted at higher concentrations (2mg/mL or greater), yielding $174–$228 monthly. Pre-mixed solutions cost 30–40% more and degrade faster, making them viable only for labs without reconstitution capabilities.

What If: Follistatin-344 Budget Scenarios

What If My Protocol Requires Dosing Every Other Day Instead of Daily?

Switch to 2mg vials and reconstitute at 1mg/mL concentration. A 2mg vial yields 20 doses of 100mcg each; at every-other-day dosing, that's 40 days of research from one vial. Your monthly cost drops to approximately $100–$125 since you're purchasing one vial every 40 days instead of every 28 days. The constraint: you're still bound by the 28-day post-reconstitution stability window, so doses administered after day 28 may show reduced biological activity.

What If I Need to Budget for Multiple Concurrent Protocols?

Purchase 5mg vials and split reconstitution across multiple sterile vials immediately upon receipt. Reconstitute 2.5mg in one vial and store the remaining 2.5mg as lyophilised powder at −20°C until needed. This extends your effective budget window because unreconstituted peptide remains stable for 12–24 months under proper storage, while reconstituted peptide degrades in 28 days. Your cost per concurrent protocol remains $145–$190 per protocol per month if each uses 100mcg daily.

What If My Research Requires Higher Doses — 300mcg Daily Instead of 100mcg?

Your monthly Follistatin-344 cost per month budget triples to $522–$684 when dosing at 300mcg daily using 5mg vials. At this dose, a single 5mg vial lasts approximately 16–17 days, requiring two vials per month. Budget $580–$760 monthly for sustained high-dose protocols. If your protocol duration is short (2–3 weeks), purchase exactly the peptide volume needed rather than rounding up to the next vial size.

The Unvarnished Reality About Follistatin-344 Research Costs

Here's the honest answer: most published research citing Follistatin-344 doesn't disclose the reconstitution errors that invalidate half their data. The peptide is notoriously unstable once mixed. Temperature excursions above 8°C, improper bacteriostatic water ratios, and contamination during multi-draw vial use all degrade peptide integrity without visible signs. A vial stored at 10°C instead of 4°C for three days loses approximately 15–25% biological activity, but there's no field test to verify this. You only discover it when your results don't replicate.

The Follistatin-344 cost per month budget conversations we see online focus entirely on sticker price and ignore the larger issue: wasted peptide from degradation and reconstitution errors represents 20–35% of total spend in most labs. You're not just paying for the peptide. You're paying for the peptide you ruin through poor handling, the peptide you throw away at day 29 because you over-reconstituted, and the peptide you re-purchase because your first batch didn't produce expected outcomes and you assumed supplier quality rather than reconstitution technique.

Most research teams underestimate the monthly Follistatin-344 cost per month budget because they calculate based on dosing frequency alone and ignore reconstitution strategy, storage constraints, and the 28-day post-mixing degradation cliff. The peptide's unit price is fixed. Your actual cost depends on how much of what you buy remains biologically active when you use it. Optimise for dose extraction per vial and cold-chain compliance, not for the lowest sticker price, and your budget drops by 25–40% without changing suppliers.

Frequently Asked Questions

[
{
"question": "How much does Follistatin-344 cost per month for a standard research protocol?",
"answer": "Follistatin-344 costs $180–$420 per month for most research protocols, with daily 100mcg dosing averaging $220–$280 when using 5mg lyophilised vials. The exact cost depends on dosing frequency, vial size selection, reconstitution volume, and whether the peptide is purchased as lyophilised powder or pre-mixed solution. Labs running sustained daily protocols achieve the best cost efficiency with 5mg vials reconstituted at 2mg/mL, yielding $174–$228 monthly."
},
{
"question": "What is the difference in cost between lyophilised Follistatin-344 and pre-mixed solutions?",
"answer": "Lyophilised Follistatin-344 costs $58–$76 per milligram in 5mg vials, while pre-mixed solutions cost $84–$108 per milligram. A 30–40% price premium for the convenience of not reconstituting the peptide yourself. Pre-mixed solutions also degrade faster, remaining stable for only 14–21 days compared to 28 days for properly reconstituted lyophilised powder stored at 2–8°C. Labs with reconstitution capabilities should always choose lyophilised powder."
},
{
"question": "How long does reconstituted Follistatin-344 remain stable, and how does that affect monthly budgeting?",
"answer": "Reconstituted Follistatin-344 remains biologically stable for approximately 28 days when stored at 2–8°C, after which peptide degradation accelerates and research outcomes become unreliable. This 28-day window is the primary constraint in monthly budget planning. You must size your vial purchases so the reconstituted volume is fully consumed within this period. Purchasing vials larger than your protocol can use in 28 days results in wasted peptide and inflated effective costs."
},
{
"question": "Can I reduce my Follistatin-344 cost per month budget by purchasing in bulk?",
"answer": "Yes, but only if you can consume the bulk volume within the 28-day post-reconstitution stability window or if you have the capability to store unreconstituted lyophilised powder at −20°C for extended periods. Purchasing 5mg vials instead of 1mg vials reduces per-milligram cost from $75–$95 to $58–$76, but reconstituting a 5mg vial that won't be fully used within 28 days wastes peptide. Bulk purchasing works when running concurrent protocols or when you can reconstitute in smaller batches as needed."
},
{
"question": "What hidden costs should I include in my Follistatin-344 monthly budget?",
"answer": "The largest hidden cost is wasted peptide from degradation and reconstitution errors, which adds 20–35% to effective monthly spend in most labs. This includes peptide lost to temperature excursions during storage, contamination during multi-draw vial use, improper bacteriostatic water ratios that accelerate degradation, and unused peptide discarded at day 29 because vial size exceeded protocol needs. Additionally, budget for bacteriostatic water ($15–$25 per 30mL bottle), sterile reconstitution vials if splitting batches ($8–$12 per pack of 10), and cold-chain storage verification tools like temperature loggers ($40–$80 one-time cost)."
},
{
"question": "How does dosing frequency affect my monthly Follistatin-344 budget?",
"answer": "Dosing frequency determines both total peptide consumption and vial utilisation efficiency. Daily 100mcg dosing requires 3mg per month, costing $174–$228 when using 5mg vials. Every-other-day dosing at the same 100mcg dose requires only 1.5mg per month, reducing costs to $100–$150 using 2mg vials. However, less frequent dosing means longer vial depletion times, which can conflict with the 28-day post-reconstitution stability limit. Plan reconstitution volume to match your dosing schedule."
},
{
"question": "Is it cheaper to buy Follistatin-344 from international suppliers?",
"answer": "International suppliers often advertise lower per-vial pricing, but the total cost-of-ownership typically exceeds domestic suppliers once you account for customs delays (which risk temperature excursions during shipping), lack of third-party purity verification, longer replacement timelines if a batch is contaminated, and the inability to verify cold-chain compliance during international transit. Domestic suppliers like Real Peptides provide verifiable storage standards, faster replacement for compromised batches, and regulatory transparency that international sources cannot match."
},
{
"question": "What vial size offers the best cost efficiency for long-term research protocols?",
"answer": "For sustained daily protocols lasting 8+ weeks, 5mg vials reconstituted at 2mg/mL concentration offer the best cost efficiency at $174–$228 per month. This vial size reduces per-milligram cost to $58–$76 and provides enough volume to last 28 days when dosed at 178mcg daily, aligning vial depletion with the post-reconstitution stability window. Smaller vials (1mg, 2mg) work better for intermittent or every-other-day protocols where lower monthly peptide consumption makes 5mg vials inefficient."
},
{
"question": "How should I calculate cost-per-dose for Follistatin-344 budget planning?",
"answer": "Divide the total vial cost by the number of usable doses the vial yields after reconstitution. A 5mg vial costing $320, reconstituted with 2.5mL bacteriostatic water at 2mg/mL concentration, yields 50 doses of 100mcg each. That's $6.40 per dose. A 1mg vial costing $85, reconstituted with 1mL at 1mg/mL, yields 10 doses of 100mcg each. That's $8.50 per dose. Cost-per-dose accounts for both purchase price and reconstitution efficiency, making it the most accurate budgeting metric."
},
{
"question": "Can I extend the usable life of reconstituted Follistatin-344 beyond 28 days?",
"answer": "No. Attempting to extend reconstituted Follistatin-344 beyond the 28-day refrigerated stability window results in progressive peptide degradation that compromises research validity. The amino acid sequence begins breaking down after approximately four weeks at 2–8°C, and there is no field-verifiable test to confirm remaining biological activity. Freezing reconstituted peptide does not stop this degradation and often accelerates it through freeze-thaw damage. The only way to extend peptide lifespan is to store it unreconstituted as lyophilised powder at −20°C until needed."
},
{
"question": "What is the monthly cost difference between 100mcg daily and 300mcg daily Follistatin-344 protocols?",
"answer": "A 100mcg daily protocol costs approximately $174–$228 per month using 5mg vials. A 300mcg daily protocol costs $522–$684 per month because you're consuming three times the peptide volume. 9mg per month instead of 3mg. Requiring two 5mg vials monthly instead of one. High-dose protocols eliminate most cost-saving opportunities because you're forced into higher vial purchase frequency regardless of reconstitution strategy."
}
]

Questions

Follistatin-344 costs $180–$420 per month for most research protocols, with daily 100mcg dosing averaging $220–$280 when using 5mg lyophilised vials. The exact cost depends on dosing frequency, vial size selection, reconstitution volume, and whether the peptide is purchased as lyophilised powder or pre-mixed solution. Labs running sustained daily protocols achieve the best cost efficiency with 5mg vials reconstituted at 2mg/mL, yielding $174–$228 monthly.
Lyophilised Follistatin-344 costs $58–$76 per milligram in 5mg vials, while pre-mixed solutions cost $84–$108 per milligram — a 30–40% price premium for the convenience of not reconstituting the peptide yourself. Pre-mixed solutions also degrade faster, remaining stable for only 14–21 days compared to 28 days for properly reconstituted lyophilised powder stored at 2–8°C. Labs with reconstitution capabilities should always choose lyophilised powder.
Reconstituted Follistatin-344 remains biologically stable for approximately 28 days when stored at 2–8°C, after which peptide degradation accelerates and research outcomes become unreliable. This 28-day window is the primary constraint in monthly budget planning — you must size your vial purchases so the reconstituted volume is fully consumed within this period. Purchasing vials larger than your protocol can use in 28 days results in wasted peptide and inflated effective costs.
Yes, but only if you can consume the bulk volume within the 28-day post-reconstitution stability window or if you have the capability to store unreconstituted lyophilised powder at −20°C for extended periods. Purchasing 5mg vials instead of 1mg vials reduces per-milligram cost from $75–$95 to $58–$76, but reconstituting a 5mg vial that won’t be fully used within 28 days wastes peptide. Bulk purchasing works when running concurrent protocols or when you can reconstitute in smaller batches as needed.
The largest hidden cost is wasted peptide from degradation and reconstitution errors, which adds 20–35% to effective monthly spend in most labs. This includes peptide lost to temperature excursions during storage, contamination during multi-draw vial use, improper bacteriostatic water ratios that accelerate degradation, and unused peptide discarded at day 29 because vial size exceeded protocol needs. Additionally, budget for bacteriostatic water ($15–$25 per 30mL bottle), sterile reconstitution vials if splitting batches ($8–$12 per pack of 10), and cold-chain storage verification tools like temperature loggers ($40–$80 one-time cost).
Dosing frequency determines both total peptide consumption and vial utilisation efficiency. Daily 100mcg dosing requires 3mg per month, costing $174–$228 when using 5mg vials. Every-other-day dosing at the same 100mcg dose requires only 1.5mg per month, reducing costs to $100–$150 using 2mg vials. However, less frequent dosing means longer vial depletion times, which can conflict with the 28-day post-reconstitution stability limit — plan reconstitution volume to match your dosing schedule.
International suppliers often advertise lower per-vial pricing, but the total cost-of-ownership typically exceeds domestic suppliers once you account for customs delays (which risk temperature excursions during shipping), lack of third-party purity verification, longer replacement timelines if a batch is contaminated, and the inability to verify cold-chain compliance during international transit. Domestic suppliers like Real Peptides provide verifiable storage standards, faster replacement for compromised batches, and regulatory transparency that international sources cannot match.
For sustained daily protocols lasting 8+ weeks, 5mg vials reconstituted at 2mg/mL concentration offer the best cost efficiency at $174–$228 per month. This vial size reduces per-milligram cost to $58–$76 and provides enough volume to last 28 days when dosed at 178mcg daily, aligning vial depletion with the post-reconstitution stability window. Smaller vials (1mg, 2mg) work better for intermittent or every-other-day protocols where lower monthly peptide consumption makes 5mg vials inefficient.
Divide the total vial cost by the number of usable doses the vial yields after reconstitution. A 5mg vial costing $320, reconstituted with 2.5mL bacteriostatic water at 2mg/mL concentration, yields 50 doses of 100mcg each — that’s $6.40 per dose. A 1mg vial costing $85, reconstituted with 1mL at 1mg/mL, yields 10 doses of 100mcg each — that’s $8.50 per dose. Cost-per-dose accounts for both purchase price and reconstitution efficiency, making it the most accurate budgeting metric.
No — attempting to extend reconstituted Follistatin-344 beyond the 28-day refrigerated stability window results in progressive peptide degradation that compromises research validity. The amino acid sequence begins breaking down after approximately four weeks at 2–8°C, and there is no field-verifiable test to confirm remaining biological activity. Freezing reconstituted peptide does not stop this degradation and often accelerates it through freeze-thaw damage. The only way to extend peptide lifespan is to store it unreconstituted as lyophilised powder at −20°C until needed.
A 100mcg daily protocol costs approximately $174–$228 per month using 5mg vials. A 300mcg daily protocol costs $522–$684 per month because you’re consuming three times the peptide volume — 9mg per month instead of 3mg — requiring two 5mg vials monthly instead of one. High-dose protocols eliminate most cost-saving opportunities because you’re forced into higher vial purchase frequency regardless of reconstitution strategy.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now